Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

Mon, 4th Nov 2019

Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1890p (from 1510p). Story provided by Broker Forecasts data provided by

FTSE 100 Latest